- $49.56m
- $50.50m
- $19.65m
Brief: Spectral AI From Time To Time, May Offer & Sell, In One Or More Offerings Up To $50 Million In Shares Of Our Common Stock
Spectral AI rises after founder Michael DiMaio returns as chairman of board
Brief: Spectral Ai, Inc. Announces Return Of Founder Dr. J. Michael Dimaio As Chairman Of The Board Of Directors
Brief: Spectral Ai Achieves 25% Patient Enrollment At Emergency Departments For U.S. Burn Pivotal Study And Adds Two New Clinical Trial Sites
Brief: Spectral AI Adds 3 Clinical Trial Sites To Expedite Emergency Department Patient Enrollment
Brief: Spectral AI Announces Collaboration with Global Wound Care Company PolyNovo to Introduce DeepView System for Burn Indication to Australian Market
Brief: Spectral AI Expands Clinical Trial Sites For Pivotal US Burn Study
Brief: Spectral Ai Inc Achieves 100% Pediatric Enrollment In Burn Centers For Pivotal U.S. Burn Study
Brief: Spectral AI Provided Support To Nasdaq And State Securities Authorities To Bring To Attention "Potential Market Manipulation" Of Co's Common Stock
Brief: Spectral AI Says On Track To File Additional UK And Us Regulatory Submissions In 2024 And 2025
Brief: Spectral AI Receives Letter From Nasdaq, Co Not Currently In Compliance With Listing Requirement On Nasdaq
Brief: Spectral AI Announces Appointment Of Erich Spangenberg To Board Of Directors
Brief: Spectral Ai Inc Files Prospectus Relates To Resale Of Up To 6.36 Mln Shares Of Common Stock By Ya Ii Pn Ltd
Brief: Spectral AI Appoints Jeremiah Sparks As Chief Commercialization Officer
Spectral AI Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: Spectral AI Secures Access To $12.5 Mln Of New Equity Capital
Brief: Spectral AI Appoints Peter M. Carlson As CEO
Brief: Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
Brief: Spectral Ai Appoints Dr. J. Michael Dimaio To Board Of Directors